Evidence map›Paper›PMID 32554537›Full record

ArticleThe European respiratory journal2020

The (in)significance of TB and COVID-19 co-infection.

Alkesh Kumar Khurana, Deepak Aggarwal

Abstract readLetterComment
In one paragraph

Article in The European respiratory journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Effects of the COVID-19 Pandemic on Patients with Tuberculosis.Journal of clinical practice and research · 2024
    Article
  2. Article
  3. Article
  4. Review
  5. EspB and HtpG interact with the type III-A CRISPR/Cas system ofFrontiers in molecular biosciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Tuberculosis Disability Adjusted Life Years, Colombia 2010-2018.Tropical medicine and infectious disease · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Fatal SARS-CoV-2 andBMJ case reports · 2021
    Article
  20. TB control in India in the COVID era.The Indian journal of tuberculosis · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Alkesh Kumar KhuranaPulmonary Medicine, All India Institute of Medical Sciences, Bhopal, India lungcancer@rediffmail.com.
Deepak AggarwalPulmonary Medicine, Govt Medical College and Hospital, Chandigarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CoinfectionCoronavirus InfectionsPandemicsPneumonia, ViralTuberculosisBetacoronavirusCOVID-19HumansSARS-CoV-2

Identifiers

PMID32554537
PMCPMC7301834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.